Influenza Vaccine
Tailor-Made Flu Viruses Now Possible
Published in Cancer Weekly, September 6th, 1999
The new technique produces influenza A viruses entirely from cloned complementary DNA (cDNA). It permits custom-designed influenza viruses and virus-like particles (VLPs).
Now it is possible to create live-virus flu vaccines more effective than the cold-adapted vaccines currently in clinical trials. Such vaccines could quickly be made in response to emerging epidemics of dangerous new influenza strains. And the ability to add new genes to customized flu viruses opens a new avenue for the development of vaccines against other diseases.
There's even...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1999-09-06)
More Articles from Cancer Weekly
- Cancer Gene Therapy
Animal Models Provide New Insights into Drug Resistance - Cancer Immunotherapy
CD154 Gene Transfer Inhibits Tumor Growth - Cancer Immunotherapy (Bladder Cancer)
BCG and IFN-(alpha) Have Synergistic Therapeutic Effect - Cancer Immunotherapy (Colorectal Cancer)
Chemo-Immunotherapy Shows Promise for Colorectal Cancer - Cancer Immunotherapy (Techniques)
Laser Immunotherapy Solutions Get Better and Better - Oncologic Pain
Pain Common in Recovered Head and Neck Cancer Patients - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
